Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome: molecular mimicry and host susceptibility.
about
Neurologic symptoms associated with cattle farming in the Agricultural Health StudyAnti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndromeGuillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbitsDevelopment of an immunoassay for rapid detection of ganglioside GM(1) mimicry in Campylobacter jejuni strainsOccupational exposure to swine, poultry, and cattle and antibody biomarkers of Campylobacter jejuni exposure and autoimmune peripheral neuropathyA processive lipid glycosyltransferase in the small human pathogen Mycoplasma pneumoniae: involvement in host immune responseNeurologic indications for therapeutic plasma exchange: an update.Neurologic indications for therapeutic plasma exchange: 2011 update.Neurologic indications for therapeutic plasma exchange: 2013 update.Campylobacter infection as a trigger for Guillain-Barré syndrome in Egypt.Genomic characterization of the Guillain-Barre syndrome-associated Campylobacter jejuni ICDCCJ07001 Isolate.New concepts of Guillain-Barré syndrome.Genetic characterization of Campylobacter jejuni O:41 isolates in relation with Guillain-Barré syndromeCampylobacter species and Guillain-Barré syndrome.Guillian Barré syndrome--recent advances.Campylobacter jejuni from patients with Guillain-Barré syndrome preferentially expresses a GD(1a)-like epitope.An update on pathobiologic roles of anti-glycan antibodies in Guillain-Barré syndrome.Treatment guidelines for Guillain-Barré Syndrome.Ganglioside molecular mimicry and its pathological roles in Guillain-Barré syndrome and related diseasesAntiganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders--a review.An update in guillain-barré syndromeAutoantobodies activate small GTPase RhoA to modulate neurite outgrowth.Assessing the safety of influenza vaccination in specific populations: children and the elderly.Guillain-Barré syndrome: causes, immunopathogenic mechanisms and treatment.Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patientsPassive transfer of IgG anti-GM1 antibodies impairs peripheral nerve repair.Potential environmental and host participants in the early white matter lesion of adreno-leukodystrophy: morphologic evidence for CD8 cytotoxic T cells, cytolysis of oligodendrocytes, and CD1-mediated lipid antigen presentation.Anti-ganglioside antibodies and clinical outcome of patients with Guillain-Barré Syndrome in northeast Brazil.Acute motor axonal neuropathy in a Turner's syndrome patient with a 'potential' celiac disease
P2860
Q23916864-7CB65204-2417-4837-947C-558ABDF53023Q28297319-35DBBC3B-39F4-4047-A5F9-163FFE4AD592Q28360460-932F53B8-0611-4A05-B4AC-1449C1F2FEB8Q28361686-D6959683-4031-4A86-8468-9C914A3A1C8AQ28395659-F89E0948-DA5F-4E29-905B-E4EB094A0DF6Q28484726-8E3DE7F2-BDAC-4E67-A601-7FB95007F9D1Q30454297-F3A6EA34-E305-4BF1-AB00-AAFC5F939150Q30455391-36426677-163F-4D6F-8A2E-4556567B6E96Q30458271-2F5B6628-ECD5-4023-A963-963ED2599127Q33383848-BA6F1B5B-B444-46C6-A0DF-335FA11F3152Q33760674-32DA3554-38CA-480D-9CD1-09D625E7E568Q33886911-FD8CB8AA-5DAF-4D48-A36B-FADCA7C89DB3Q33965648-984EFD76-B101-4E26-820C-0FC619AC9129Q33975353-2C6B61AB-C1E8-44EE-A31E-B49DF40F350EQ34058083-03461C68-A40D-4523-809E-846BA35F418CQ34130499-D061EEE9-E5EC-4D16-B874-3F785F4BA3DDQ34167468-082245CD-9F7B-46F4-AE6F-2E3BDC54ABEAQ35152989-DF35DFC0-A82B-45F1-B244-9DEBE6AB9D67Q35220367-7D8E839B-DCED-49D5-AAE2-763063A848C3Q37207391-68B51D79-442F-4972-ACA7-8FF1948E850FQ37544140-5EFDA3A5-0D50-4753-983A-9E1831675A8BQ37965171-44312E6C-C4CF-4789-BA60-1A9542CF4180Q38045920-02221868-C7E7-4FDD-AF97-E61FEFAB5327Q38862736-6EE55CC5-FF63-4168-A2DD-6A6683C02D1AQ39654221-CE7406F5-56B6-4935-9292-B160B9B7D21DQ42600854-C5DCA231-3D58-4A55-8373-BDA44E8AB505Q48762668-670A9D0A-3AD7-4E03-8FE3-4267CF3953F7Q51663570-C9EB21B0-1108-4FFE-9084-DC7EE715ECC0Q57927833-D96A3A12-5250-4D98-A9D8-FF7B184252BD
P2860
Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome: molecular mimicry and host susceptibility.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Campylobacter jejuni lipopolys ...... micry and host susceptibility.
@en
Campylobacter jejuni lipopolys ...... micry and host susceptibility.
@nl
type
label
Campylobacter jejuni lipopolys ...... micry and host susceptibility.
@en
Campylobacter jejuni lipopolys ...... micry and host susceptibility.
@nl
prefLabel
Campylobacter jejuni lipopolys ...... micry and host susceptibility.
@en
Campylobacter jejuni lipopolys ...... micry and host susceptibility.
@nl
P2093
P921
P356
P1433
P1476
Campylobacter jejuni lipopolys ...... micry and host susceptibility.
@en
P2093
Cornblath DR
Griffin JW
McKhann GM
Nachamkin I
Nicholson M
P304
P356
10.1212/WNL.51.2.371
P407
P50
P577
1998-08-01T00:00:00Z